Wednesday, January 7, 2009
Neotrope®

eNewsChannels - Business, Entertainment and Technology News
   
 Belgium Business, Entertainment and Technology News
    
Most Popular News in this News Category:
  • A Step Ahead of Resistance - Virco introduces an Improved Rapid Methodology to Establish New HIV-1 Resistance Profiles for Recently Approved Protease Inhibitors PREZISTA and Aptivus
  • Leading Streaming Media Company Provides Advanced IPTV and Internet TV Content Delivery Solutions


  • Most Popular News:
  • M.A.D.E. Planet Links Music Artists to Entertainment Industry
  • Capital Market Tech Partners with Better ATM Services
  • Working Together: Keys to the Secret in Relationships
  • Personal Finance Newsletter for Young Adults Can Be a Smart Graduation Gift
  • Ballantine Corporation Releases Updated Direct Mail Control Report for 2008
  • Holistic Pet: Increase Your Pet's Longevity with a Healthy Liver
  • Controversial Sculptor Daniel Edwards Debuts Golden OPRAH
  • Native Voices: 7.7.07 Lowers Earth Temp, 7/17 Energizes Oceans
  • Perillo Tours Offers Free Air Fare to Italy via Milan's EuroFly Airlines
  • Author and Nurse Paul Genesse Gives Dragons A Shot with New Book
  •  

    Leading Streaming Media Company Provides Advanced IPTV and Internet TV Content Delivery Solutions

    Wed, 09 May 2007 20:25:40 -0700 PDT
    by Tabitha Berg - Staff Editor

    BRASSCHAAT, Belgium — With the help of Streaming Group’s streaming technology and software solutions for Video on Demand (VoD), IPTV, and live broadcast over broadband networks, telecommunication networks and advertisers are able to deliver the finest quality content to their customers all over the world.

    A Step Ahead of Resistance - Virco introduces an Improved Rapid Methodology to Establish New HIV-1 Resistance Profiles for Recently Approved Protease Inhibitors PREZISTA and Aptivus

    Tue, 17 Oct 2006 03:48:21 -0700 PDT
    by Aria Munro - Staff Editor

    MECHELEN, Belgium — Responding to the need to make timely evaluations and decisions when treating treatment experienced HIV patients, Virco Labs (www.vircolab.com), a leader in drug resistance testing recently introduced an improved virco(R)TYPE HIV-1 test that rapidly determines the complex phenotypic resistance profiles for darunavir, tipranavir and other antiretroviral (ARV) drugs.



    eNewsChannels References: A Step Ahead of Resistance - Virco introduces an Improved Rapid Methodology to Establish New HIV-1 Resistance Profiles for Recently Approved Protease Inhibitors PREZISTA and Aptivus - Tue, 17 Oct 2006 Top of Page  |  Home Page  |  RSS 2.0 Feed XML  |  A9 SiteInfo Toolbar XML